Weight Considerations in Pharmacotherapy for Type 2 Diabetes
Obesity has been increasing in prevalence worldwide and the majority of patients with type 2 diabetes are either overweight or obese. Diabetes management in this population has been difficult since a number of antidiabetes agents are associated with weight gain. The effects of various antidiabetes a...
Saved in:
Main Authors: | Vicky Cheng, Sangeeta R. Kashyap |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2011-01-01
|
Series: | Journal of Obesity |
Online Access: | http://dx.doi.org/10.1155/2011/984245 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
The Application of Incretin-Based Pharmacotherapy in the Contemporary Management of Type 2 Diabetes: A Review of the Literature
by: Jakub Waszczyński, et al.
Published: (2025-01-01) -
Current Advances in Pharmacotherapy and Technology for Diabetic Retinopathy: A Systematic Review
by: Lei Lu, et al.
Published: (2018-01-01) -
Pharmacotherapy of Posttraumatic Cognitive Impairments
by: David B. Arciniegas, et al.
Published: (2006-01-01) -
Pharmacotherapy of Peptic Ulcer Disease
by: F Molina, et al.
Published: (1991-01-01) -
The Pharmacotherapy of Chronic Pain: A Review
by: Mary E Lynch, et al.
Published: (2006-01-01)